Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety
Authors (first, second and last of 8)
As an international journal, DARU Journal of Pharmaceutical Sciences considers outstanding studies from basic research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community. Therefore, the journal welcomes submissions from all over the world.
- Considers outstanding studies from basic research to clinical investigations
- Indexed in Medline, Scopus, PubMed, Science Citaion Index
- No Article Processing charges
Journal information
- Editor-in-Chief
-
- Mohammad Abdollahi
- Publishing model
- Hybrid. Learn about publishing OA with us
Journal metrics
- 2.739 (2019)
- Impact factor
- 3.027 (2019)
- Five year impact factor
- 28 days
- Submission to first decision
- 163 days
- Submission to acceptance
- 106,296 (2019)
- Downloads
Latest issue
Latest articles
-
-
Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity
Authors (first, second and last of 5)
-
Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial
Authors (first, second and last of 8)
-
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
Authors (first, second and last of 13)
-
COVID-19 vaccines: ethical framework concerning human challenge studies
Authors (first, second and last of 8)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Follow us on Twitter
DARU Journal of Pharmaceutical Sciences (@DaruSci) is on Twitter. Follow us and keep up to date with the latest journal news, research highlights, and more.
-
Follow us on LinkedIn
DARU Journal of Pharmaceutical Sciences is on LinkedIn.
About this journal
- Electronic ISSN
- 2008-2231
- Abstracted and indexed in
-
- BIOSIS
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Dimensions
- EBSCO Academic Search
- EBSCO Belt and Road Initiative Reference Source
- EBSCO Biomedical Reference Collection
- EBSCO CINAHL
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Gale
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Middle East & Africa Database
- ProQuest Research Library
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
